Utzinger J, Xiao SH, N’Goran EK, Bergquist R, Tanner M, 2001. The potential of artemether for the control of schistosomiasis. Int J Parasitol 31 :1549–1562.
N’Goran EK, Utzinger J, Gnaka HN, Yapi A, N’Guessan NA, Kigbafori SD, Lengeler C, Chollet J, Xiao SH, Tanner M, 2003. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg 68 :24–32.
N’Goran EK, Utzinger J, N’Guessan AN, Müller I, Zamblé K, Lohourignon KL, Traoré M, Sosthène BA, Lengeler C, Tanner M, 2001. Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d’Ivoire. Trop Med Int Health 6 :817–825.
World Health Organization, 1998. The Use of Artemisinin and its Derivatives as Anti-Malarial Drugs: Report of a Joint CTD/ DMP/TDR Informal Consultation. Geneva: World Health Organization.
Meshnick SR, 2002. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 32 :1655–1660.
Hastings IM, Watkins WM, White NJ, 2002. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc Lond B Biol Sci 357 :505–519.
Utzinger J, Keiser J, Xiao SH, Tanner M, Singer BH, 2003. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47 :1487–1495.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1081 | 1010 | 527 |
Full Text Views | 211 | 10 | 2 |
PDF Downloads | 33 | 8 | 0 |
Utzinger J, Xiao SH, N’Goran EK, Bergquist R, Tanner M, 2001. The potential of artemether for the control of schistosomiasis. Int J Parasitol 31 :1549–1562.
N’Goran EK, Utzinger J, Gnaka HN, Yapi A, N’Guessan NA, Kigbafori SD, Lengeler C, Chollet J, Xiao SH, Tanner M, 2003. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. Am J Trop Med Hyg 68 :24–32.
N’Goran EK, Utzinger J, N’Guessan AN, Müller I, Zamblé K, Lohourignon KL, Traoré M, Sosthène BA, Lengeler C, Tanner M, 2001. Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d’Ivoire. Trop Med Int Health 6 :817–825.
World Health Organization, 1998. The Use of Artemisinin and its Derivatives as Anti-Malarial Drugs: Report of a Joint CTD/ DMP/TDR Informal Consultation. Geneva: World Health Organization.
Meshnick SR, 2002. Artemisinin: mechanisms of action, resistance and toxicity. Int J Parasitol 32 :1655–1660.
Hastings IM, Watkins WM, White NJ, 2002. The evolution of drug-resistant malaria: the role of drug elimination half-life. Philos Trans R Soc Lond B Biol Sci 357 :505–519.
Utzinger J, Keiser J, Xiao SH, Tanner M, Singer BH, 2003. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47 :1487–1495.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1081 | 1010 | 527 |
Full Text Views | 211 | 10 | 2 |
PDF Downloads | 33 | 8 | 0 |